Ling Xu
- Molecular Biology
- Physiology
- Endocrinology, Diabetes and Metabolism top 10%
- Cardiology and Cardiovascular Medicine top 10%
- Oncology
- Co-authors
- Mei ChengVirginia L. BrooksBaoying LiXianhua LiHaiqing GaoAlan F. SvedConstance I. NugentRuben C. Petreaca
- Topics
- Advanced Glycation End Products research (5 papers)DNA Repair Mechanisms (3 papers)CRISPR and Genetic Engineering (3 papers)
- Cited by
- AgingPeriodonticsNeurology
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryNature Cell Biology
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Ling Xu
50 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 107
- Molecular Biology 383
- Physiology 183
- Endocrinology, Diabetes and Metabolism 155
- Cardiology and Cardiovascular Medicine 146
- Oncology 118
Countries citing papers authored by Ling Xu
This map shows the geographic impact of Ling Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Xu more than expected).
Fields of papers citing papers by Ling Xu
This network shows the impact of papers produced by Ling Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Xu. The network helps show where Ling Xu may publish in the future.
Co-authorship network of co-authors of Ling Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Ling Xu. A scholar is included among the top collaborators of Ling Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Xu. Ling Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 13 | |
| 4 | 3 | |
| 5 | 7 | |
| 6 | 1 | |
| 7 | 117 | |
| 8 | 3 | |
| 9 | 1 | |
| 10 | 20 | |
| 11 | 5 | |
| 12 | 13 | |
| 13 | 67 | |
| 14 | 60 | |
| 15 | Effects of bazedoxifene (TSE-424), a novel tissue selective estrogen receptor modulator (SERM), on biochemical markers of bone metabolism in a chinese population | 1 |
| 16 | 23 | |
| 17 | 48 | |
| 18 | 30 | |
| 19 | 22 | |
| 20 | 12 |
About Ling Xu
Ling Xu is a scholar working on Clinical Biochemistry, Aging and Behavioral Neuroscience, having authored 54 papers that have together received 1.1k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (5 papers), DNA Repair Mechanisms (3 papers) and CRISPR and Genetic Engineering (3 papers). The work is most often cited by research in Aging (30 citations), Periodontics (62 citations) and Neurology (96 citations). Ling Xu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Mei Cheng, Virginia L. Brooks, Baoying Li, Xianhua Li, Haiqing Gao, Alan F. Sved, Constance I. Nugent, Ruben C. Petreaca, Gang Chen and Yang Liu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.